| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Plasma, oral fluid and sweat wipe ecstasy concentrations in controlled and real life conditions.
|
Forensic Sci Int
|
2002
|
1.02
|
|
2
|
Validation of an ELISA-based screening assay for the detection of amphetamine, MDMA and MDA in blood and oral fluid.
|
Forensic Sci Int
|
2005
|
1.01
|
|
3
|
Toxicological data and growth characteristics of single post-feeding larvae and puparia of Calliphora vicina (Diptera: Calliphoridae) obtained from a controlled nordiazepam study.
|
Int J Legal Med
|
2004
|
0.97
|
|
4
|
Evaluation of on-site oral fluid screening using Drugwipe-5(+), RapidSTAT and Drug Test 5000 for the detection of drugs of abuse in drivers.
|
Forensic Sci Int
|
2009
|
0.97
|
|
5
|
Oxidative DNA damage: biological significance and methods of analysis.
|
Crit Rev Clin Lab Sci
|
2002
|
0.97
|
|
6
|
Correlation of Delta9-tetrahydrocannabinol concentrations determined by LC-MS-MS in oral fluid and plasma from impaired drivers and evaluation of the on-site Dräger DrugTest.
|
Forensic Sci Int
|
2006
|
0.92
|
|
7
|
The use of oral fluid and sweat wipes for the detection of drugs of abuse in drivers.
|
J Forensic Sci
|
2002
|
0.90
|
|
8
|
Simultaneous analysis of THC and its metabolites in blood using liquid chromatography-tandem mass spectrometry.
|
J Chromatogr B Analyt Technol Biomed Life Sci
|
2008
|
0.88
|
|
9
|
Quantitative analysis of multiple illicit drugs in preserved oral fluid by solid-phase extraction and liquid chromatography-tandem mass spectrometry.
|
Forensic Sci Int
|
2005
|
0.88
|
|
10
|
On-line solid-phase extraction combined with liquid chromatography-tandem mass spectrometry for high throughput analysis of 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid in urine.
|
J Chromatogr B Analyt Technol Biomed Life Sci
|
2009
|
0.86
|
|
11
|
Detection of diazepam in urine, hair and preserved oral fluid samples with LC-MS-MS after single and repeated administration of Myolastan and Valium.
|
Anal Bioanal Chem
|
2007
|
0.85
|
|
12
|
Single-pass isolated lung perfusion versus recirculating isolated lung perfusion with melphalan in a rat model.
|
Ann Thorac Surg
|
2002
|
0.83
|
|
13
|
Docetaxel and gemcitabine combination therapy in advanced transitional cell carcinoma of the urothelium: results of a phase II and pharmacologic study.
|
Anticancer Drugs
|
2007
|
0.82
|
|
14
|
Liquid chromatography-tandem mass spectrometry method for the simultaneous analysis of multiple hallucinogens, chlorpheniramine, ketamine, ritalinic acid, and metabolites, in urine.
|
J Anal Toxicol
|
2007
|
0.82
|
|
15
|
Everolimus alters imatinib blood partition in favour of the erythrocyte.
|
J Pharm Pharmacol
|
2006
|
0.81
|
|
16
|
Quantitative analysis of delta9-tetrahydrocannabinol in preserved oral fluid by liquid chromatography-tandem mass spectrometry.
|
J Chromatogr A
|
2005
|
0.81
|
|
17
|
Conventional and alternative matrices for driving under the influence of cannabis: recent progress and remaining challenges.
|
Bioanalysis
|
2010
|
0.80
|
|
18
|
Bioanalytical procedures for determination of drugs of abuse in oral fluid.
|
Anal Bioanal Chem
|
2007
|
0.80
|
|
19
|
Validation of a liquid chromatography-tandem mass spectrometry method for the simultaneous determination of 26 benzodiazepines and metabolites, zolpidem and zopiclone, in blood, urine, and hair.
|
J Anal Toxicol
|
2005
|
0.80
|
|
20
|
Entomotoxicology, experimental set-up and interpretation for forensic toxicologists.
|
Forensic Sci Int
|
2011
|
0.79
|
|
21
|
Detection of flunitrazepam and 7-aminoflunitrazepam in oral fluid after controlled administration of rohypnol.
|
J Anal Toxicol
|
2002
|
0.78
|
|
22
|
Quantification of the anticancer agent STI-571 in erythrocytes and plasma by measurement of sediment technology and liquid chromatography-tandem mass spectrometry.
|
J Chromatogr A
|
2003
|
0.78
|
|
23
|
Recent applications of liquid chromatography-mass spectrometry in forensic science.
|
J Chromatogr A
|
2006
|
0.78
|
|
24
|
Simultaneous analysis of gamma-hydroxybutyric acid and its precursors in urine using liquid chromatography-tandem mass spectrometry.
|
J Chromatogr A
|
2004
|
0.78
|
|
25
|
High-throughput analysis of amphetamines in blood and urine with online solid-phase extraction-liquid chromatography-tandem mass spectrometry.
|
J Anal Toxicol
|
2009
|
0.78
|
|
26
|
Regional differences of melphalan lung levels after isolated lung perfusion in the rat.
|
J Surg Res
|
2005
|
0.76
|
|
27
|
High-throughput on-line solid-phase extraction-liquid chromatography-tandem mass spectrometry method for the simultaneous analysis of 14 antidepressants and their metabolites in plasma.
|
J Chromatogr A
|
2007
|
0.76
|
|
28
|
Proteomics in cancer research: methods and application of array-based protein profiling technologies.
|
Anal Chim Acta
|
2005
|
0.76
|
|
29
|
In vitro partition of irinotecan (CPT-11) in human volunteer blood: the influence of concentration, gender and smoking.
|
Anticancer Drugs
|
2005
|
0.75
|
|
30
|
Pharmacokinetics after pulmonary artery perfusion with gemcitabine.
|
Ann Thorac Surg
|
2003
|
0.75
|
|
31
|
Imatinib (Gleevec, Glivec) tumour tissue analysis by measurement of sediment and by liquid chromatography tandem mass spectrometry.
|
J Sep Sci
|
2006
|
0.75
|
|
32
|
Quantification of methadone and its metabolite 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine in third instar larvae of Lucilia sericata (Diptera: Calliphoridae) using liquid chromatography-tandem mass spectrometry.
|
J Anal Toxicol
|
2010
|
0.75
|
|
33
|
Simultaneous determination of AMN107 and Imatinib (Gleevec, Glivec, STI571) in cultured tumour cells using an isocratic high-performance liquid chromatography procedure with UV detection.
|
J Chromatogr B Analyt Technol Biomed Life Sci
|
2006
|
0.75
|
|
34
|
Unexpected interactions between nicotinamide and CPT-11 in a rhabdomyosarcoma tumor model.
|
Anticancer Res
|
2003
|
0.75
|
|
35
|
In vitro partition of docetaxel and gemcitabine in human volunteer blood: the influence of concentration and gender.
|
Anticancer Drugs
|
2005
|
0.75
|
|
36
|
The relevance of therapeutic drug monitoring in plasma and erythrocytes in anti-cancer drug treatment.
|
Clin Chem Lab Med
|
2004
|
0.75
|
|
37
|
Pharmacokinetics of gemcitabine when delivered by selective pulmonary artery perfusion for the treatment of lung cancer.
|
Drug Metab Dispos
|
2008
|
0.75
|